Clinical Trials
2 trialsNCT07566897 2026-05-05
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
Philogen S.p.A.
Phase 1 Not yet recruiting
NCT04303403 2023-10-11
Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
National Cancer Centre, Singapore
Phase 1 Unknown